Kwality Pharmaceuticals Ltd. - Research Center
539997 KPL Group (B) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
10.38 |
10.38 |
10.38 |
10.38 |
10.38 |
Share application money
Preference share capital
Reserves & surplus
190.85 |
171.38 |
51.33 |
35.92 |
27.49 |
Secured loans
90.26 |
43.29 |
32.65 |
29.32 |
25.74 |
Unsecured loans
Total
291.49 |
225.05 |
96.43 |
77.71 |
63.60 |
Gross block
168.72 |
126.70 |
83.69 |
61.18 |
46.26 |
Less : revaluation reserve
Less : accumulated depreciation
49.15 |
35.93 |
25.27 |
19.55 |
18.24 |
Net block
118.77 |
89.97 |
57.61 |
40.83 |
27.22 |
Capital work-in-progress
Investments
Current assets, loans & advances
219.17 |
235.43 |
101.65 |
85.51 |
70.51 |
Less : current liabilities & provisions
64.29 |
116.83 |
71.56 |
56.17 |
42.59 |
Total net current assets
154.88 |
118.60 |
30.10 |
29.34 |
27.92 |
Miscellaneous expenses not written
Total
291.49 |
225.05 |
96.43 |
77.71 |
63.60 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
103.76 |
103.76 |
103.76 |
103.76 |
103.76 |